CardiAI

CardiAI is a Calgary-based private healthcare technology and medical device company developing AI-enabled diagnostic devices and software for cardiovascular and other chronic conditions. The company focuses on point-of-care diagnostics, including lateral flow and microfluidic platforms, as well as connected monitoring tools with cloud analytics and EHR integration. Publicly described products include BPAro, an ambulatory blood pressure monitoring system, and cardiac troponin I testing solutions for early myocardial damage detection and cardiovascular risk stratification. CardiAI has also described work in AI-assisted analysis of Holter monitor and cardiac imaging data, and has been associated with broader precision-health activities through BioAro. Overall, CardiAI appears to operate at the intersection of medtech, diagnostics, and digital health rather than as a therapeutics developer.